Effect of a novel potential atypical antipsychotic drug, Y-931, in producing dystonia in Cebus monkeys

Yasuyuki Shiigi, Jun Ichi Maeda, Hiroshi Yasumatsu, Hiroshi Tanaka, Daniel Casey

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The effect of Y-931 (8-fluoro-12-(4-methylpiperazin-1-yl)-6H-[1]benzothieno[2,3-b][1,5]benzodiazepin e maleate), a novel potential atypical antipsychotic candidate, in producing dystonia in Cebus monkeys was investigated. Y-931 induced relatively weak dystonia in several observation periods at doses greater than 0.1 mg/kg, i.m. Although Y-931 significantly increased total dystonia scores (the sum of 15 to 360 min after injection) at doses greater than 0.5 mg/kg, i.m., the scores did not exceed 20, up to a dose of 1.0 mg/kg, i.m. and lacked a dose-response relationship. The present result suggests that Y-931 is predicted to have a low risk of extrapyramidal side effects.

Original languageEnglish (US)
Pages (from-to)364-366
Number of pages3
JournalJournal of Pharmacological Sciences
Volume93
Issue number3
DOIs
StatePublished - Nov 2003
Externally publishedYes

Fingerprint

Cebus
Dystonia
Antipsychotic Agents
Haplorhini
Observation
Injections
8-fluoro-12-(4-methylpiperazin-1-yl)-6H-(1)benzothieno(2,3-b)(1,5)benzodiazepine

Keywords

  • Dystonia
  • Monkey
  • Y-931

ASJC Scopus subject areas

  • Pharmacology

Cite this

Effect of a novel potential atypical antipsychotic drug, Y-931, in producing dystonia in Cebus monkeys. / Shiigi, Yasuyuki; Maeda, Jun Ichi; Yasumatsu, Hiroshi; Tanaka, Hiroshi; Casey, Daniel.

In: Journal of Pharmacological Sciences, Vol. 93, No. 3, 11.2003, p. 364-366.

Research output: Contribution to journalArticle

Shiigi, Yasuyuki ; Maeda, Jun Ichi ; Yasumatsu, Hiroshi ; Tanaka, Hiroshi ; Casey, Daniel. / Effect of a novel potential atypical antipsychotic drug, Y-931, in producing dystonia in Cebus monkeys. In: Journal of Pharmacological Sciences. 2003 ; Vol. 93, No. 3. pp. 364-366.
@article{07a4c19eeac64ddbbf61bad227881574,
title = "Effect of a novel potential atypical antipsychotic drug, Y-931, in producing dystonia in Cebus monkeys",
abstract = "The effect of Y-931 (8-fluoro-12-(4-methylpiperazin-1-yl)-6H-[1]benzothieno[2,3-b][1,5]benzodiazepin e maleate), a novel potential atypical antipsychotic candidate, in producing dystonia in Cebus monkeys was investigated. Y-931 induced relatively weak dystonia in several observation periods at doses greater than 0.1 mg/kg, i.m. Although Y-931 significantly increased total dystonia scores (the sum of 15 to 360 min after injection) at doses greater than 0.5 mg/kg, i.m., the scores did not exceed 20, up to a dose of 1.0 mg/kg, i.m. and lacked a dose-response relationship. The present result suggests that Y-931 is predicted to have a low risk of extrapyramidal side effects.",
keywords = "Dystonia, Monkey, Y-931",
author = "Yasuyuki Shiigi and Maeda, {Jun Ichi} and Hiroshi Yasumatsu and Hiroshi Tanaka and Daniel Casey",
year = "2003",
month = "11",
doi = "10.1254/jphs.93.364",
language = "English (US)",
volume = "93",
pages = "364--366",
journal = "Journal of Pharmacological Sciences",
issn = "1347-8648",
publisher = "Japanese Pharmacological Society",
number = "3",

}

TY - JOUR

T1 - Effect of a novel potential atypical antipsychotic drug, Y-931, in producing dystonia in Cebus monkeys

AU - Shiigi, Yasuyuki

AU - Maeda, Jun Ichi

AU - Yasumatsu, Hiroshi

AU - Tanaka, Hiroshi

AU - Casey, Daniel

PY - 2003/11

Y1 - 2003/11

N2 - The effect of Y-931 (8-fluoro-12-(4-methylpiperazin-1-yl)-6H-[1]benzothieno[2,3-b][1,5]benzodiazepin e maleate), a novel potential atypical antipsychotic candidate, in producing dystonia in Cebus monkeys was investigated. Y-931 induced relatively weak dystonia in several observation periods at doses greater than 0.1 mg/kg, i.m. Although Y-931 significantly increased total dystonia scores (the sum of 15 to 360 min after injection) at doses greater than 0.5 mg/kg, i.m., the scores did not exceed 20, up to a dose of 1.0 mg/kg, i.m. and lacked a dose-response relationship. The present result suggests that Y-931 is predicted to have a low risk of extrapyramidal side effects.

AB - The effect of Y-931 (8-fluoro-12-(4-methylpiperazin-1-yl)-6H-[1]benzothieno[2,3-b][1,5]benzodiazepin e maleate), a novel potential atypical antipsychotic candidate, in producing dystonia in Cebus monkeys was investigated. Y-931 induced relatively weak dystonia in several observation periods at doses greater than 0.1 mg/kg, i.m. Although Y-931 significantly increased total dystonia scores (the sum of 15 to 360 min after injection) at doses greater than 0.5 mg/kg, i.m., the scores did not exceed 20, up to a dose of 1.0 mg/kg, i.m. and lacked a dose-response relationship. The present result suggests that Y-931 is predicted to have a low risk of extrapyramidal side effects.

KW - Dystonia

KW - Monkey

KW - Y-931

UR - http://www.scopus.com/inward/record.url?scp=0346874516&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0346874516&partnerID=8YFLogxK

U2 - 10.1254/jphs.93.364

DO - 10.1254/jphs.93.364

M3 - Article

C2 - 14646255

AN - SCOPUS:0346874516

VL - 93

SP - 364

EP - 366

JO - Journal of Pharmacological Sciences

JF - Journal of Pharmacological Sciences

SN - 1347-8648

IS - 3

ER -